Related Experiment Video

Updated: Jul 8, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

TLR signaling by tumor and immune cells: a double-edged sword

B Huang1, J Zhao, J C Unkeless

  • 1Department of Biochemistry and Molecular Biology, Tongji Medical College, Wuhan, China. tjhuangbo@yahoo.com

Oncogene
|January 8, 2008
PubMed

Insights

Toll-like receptors (TLRs) on tumor cells promote cancer progression, enhancing proliferation, metastasis, and immune evasion. Targeting these tumor cell TLR signaling pathways offers potential new cancer therapies.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Tumor cell signaling pathways driving cancer progression (proliferation, apoptosis resistance, metastasis, immune evasion) are incompletely understood.
  • Toll-like receptors (TLRs) are key in innate and adaptive immunity, recognizing pathogen-associated molecular patterns.
  • Functional TLRs are increasingly found on various tumor cells, suggesting roles in cancer biology.

Purpose of the Study:

  • To investigate the role of Toll-like receptors (TLRs) expressed on tumor cells in cancer progression.
  • To explore how tumor cell TLR activation influences key cancer hallmarks and immune evasion mechanisms.
  • To evaluate the therapeutic potential of targeting tumor cell TLR signaling pathways.

Main Methods:

  • Review of current literature on Toll-like receptor (TLR) expression and function in various tumor types.
  • Analysis of studies investigating the impact of TLR activation on tumor cell proliferation, apoptosis, invasion, and metastasis.
  • Examination of research on TLR-induced modulation of the tumor microenvironment and immune response.

Main Results:

  • Activation of Toll-like receptors (TLRs) on tumor cells promotes uncontrolled proliferation and resistance to apoptosis.
  • Tumor cell TLR signaling enhances invasion and metastasis via regulation of metalloproteinases and integrins.
  • TLR activation in cancer cells induces factors that promote immune evasion and resistance to cytotoxic lymphocytes.

Conclusions:

  • Neoplastic processes appear to hijack Toll-like receptor (TLR) signaling pathways to advance cancer progression.
  • Targeting tumor cell TLR signaling represents a promising novel therapeutic strategy for cancer treatment.
  • Further research into tumor-specific TLR functions could reveal new avenues for anti-cancer therapies.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...